A study on American Joint Committee on Cancer stages I to III primary breast cancers and normal breast specimens found that B7-H3 was expressed in 32 out of 82 primary breast tumors and compared with normal breast tissue, B7-H3 expression in primary tumors had a significant correlation with increased tumor size and lymph vascular invasion (33). Here, CD276 is linked to breast cancer.